HAL (France)open access
The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France
COVID-19, Cardiac amyloidosis, 0, Burden, Care pathway, 1, Self-reported questionnaire, Patient experience
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 311925
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.